| Title | Niacin therapy improves outcome and normalizes metabolic abnormalities in an NAXD-deficient patient. |
| Publication Type | Journal Article |
| Year of Publication | 2022 |
| Authors | Manor, J, Calame, DG, Gijavanekar, C, Tran, A, Fatih, JM, Lalani, SR, Mizerik, E, Parnes, M, Mehta, VP, Adesina, AM, Lupski, JR, Scaglia, F, Elsea, SH |
| Journal | Brain |
| Volume | 145 |
| Issue | 5 |
| Pagination | e36-e40 |
| Date Published | 2022 Jun 03 |
| ISSN | 1460-2156 |
| Keywords | Cholesterol, HDL, Humans, Niacin |
| DOI | 10.1093/brain/awac065 |
| Alternate Journal | Brain |
| PubMed ID | 35231119 |
| Grant List | U54 HG006542 / HG / NHGRI NIH HHS / United States UM1 HG006542 / HG / NHGRI NIH HHS / United States R35 NS105078 / NS / NINDS NIH HHS / United States R01 CA211176 / CA / NCI NIH HHS / United States T32 NS043124 / NS / NINDS NIH HHS / United States |
Niacin therapy improves outcome and normalizes metabolic abnormalities in an NAXD-deficient patient.
Similar Publications
| . Deep sequencing of candidate genes identified 14 variants associated with smoking abstinence in an ethnically diverse sample. Sci Rep. 2024;14(1):6385. |
| . FAIR Header Reference genome: a TRUSTworthy standard. Brief Bioinform. 2024;25(3). |
| . Gut Microbiota and Blood Metabolites Related to Fiber Intake and Type 2 Diabetes. Circ Res. 2024;134(7):842-854. |